Framework for a national teleretinal imaging program to screen for diabetic retinopathy in Veterans Health Administration patients

Digital retinal imaging with remote image interpretation (teleretinal imaging) is an emerging healthcare technology for screening patients for diabetic retinopathy (DR). The Veterans Health Administration (VHA) convened an expert panel in 2001 to determine and resolve the requisite clinical, quality...

Full description

Saved in:
Bibliographic Details
Published inJournal of rehabilitation research and development Vol. 43; no. 6; pp. 741 - 748
Main Authors Conlin, Paul R, Fisch, Barry M, Orcutt, James C, Hetrick, Barbara J, Darkins, Adam W
Format Journal Article
LanguageEnglish
Published United States Department of Veterans Affairs 01.09.2006
Superintendent of Documents
Subjects
Ambulatory care
Care and treatment
Clinical outcomes
Consensus Development Conferences as Topic
Diabetes
Diabetic retinopathy
Diabetic Retinopathy - diagnosis
Diagnosis
Diagnostic imaging
Early intervention
Eye diseases
Health care
Health services
Hospitals
Humans
Mass Screening
Patient safety
Practice Guidelines as Topic
Program Development
Quality of care
Technological change
Telemedicine
United States
United States Department of Veterans Affairs
Veterans
United States
Online AccessGet full text

Cover

More Information
Summary:Digital retinal imaging with remote image interpretation (teleretinal imaging) is an emerging healthcare technology for screening patients for diabetic retinopathy (DR). The Veterans Health Administration (VHA) convened an expert panel in 2001 to determine and resolve the requisite clinical, quality and training, information technology, and healthcare infrastructure issues associated with deploying a teleretinal imaging system. The panel formulated consensus recommendations based on available literature and identified areas of uncertainty that merited further clarification or research. Subsequent VHA experience with teleretinal imaging and accumulated scientific evidence support nationwide regionalized deployment of teleretinal imaging to screen for DR. The goal is to screen approximately 75,000 patients in the first year of the program, which commenced in 2006. This program will increase patients' access to screening for DR, provide outcomes data, and offer a unique platform for systematically evaluating the role of this technology in the care of diabetic eye disease and routine eye-care practice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0748-7711
1938-1352
DOI:10.1682/JRRD.2005.08.0146